Sarró, S, Pomarol-Clotet, E, Canales-Rodríguez, EJ, Salvador, R, Gomar, JJ, Ortiz-Gil, J, et al. Structural brain changes associated with tardive dyskinesia in schizophrenia. Br J Psychiatry
2013; 203: 51–7.
Owens, DG, Johnstone, EC, Frith, CD. Spontaneous involuntary disorders of movement: their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neuroleptics. Arch Gen Psychiatry
1982; 39: 452–61.
Glazer, WM, Hafez, H. A comparison of masking effects of haloperidol versus molindone in tardive dyskinesia. Schizophr Res
1990; 3: 315–20.
Kegeles, LS, Abi-Dargham, A, Frankle, WG, Gil, R, Cooper, TB, Slifstein, M, et al. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. Arch Gen Psychiatry
2010; 67: 231–9.
Laruelle, M, Abi-Dargham, A, Gil, R, Kegeles, L, Innis, R. Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol Psychiatry
1999; 46: 56–72.
Palaniyappan, L, Balain, V, Radua, J, Liddle, PF. Structural correlates of auditory hallucinations in schizophrenia: a meta-analysis. Schizophr Res
2012; 46: 1249–56.
Palaniyappan, L, Liddle, PF. Does the salience network play a cardinal role in psychosis? An emerging hypothesis of insular dysfunction. J Psychiatry Neurosci
2012; 37: 17–27.
Hayashi-Takagi, A, Sawa, A. Disturbed synaptic connectivity in schizophrenia: convergence of genetic risk factors during neurodevelopment. Brain Res Bull
2010; 83: 140–6.
Liddle, PF, Barnes, TR, Speller, J, Kibel, D. Negative symptoms as a risk factor for tardive dyskinesia in schizophrenia. Br J Psychiatry
1993; 163: 776–80.
Morgenstern, H, Glazer, WM. Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale tardive dyskinesia study. Arch Gen Psychiatry
1993; 50: 723–33.
Morgenstern, H, Glazer, WM, Niedzwiecki, D, Nourjah, P. The impact of neuroleptic medication on tardive dyskinesia: a meta-analysis of published studies. Am J Public Health
1987; 77: 717–24.
Ebdrup, BH, Nørbak, H, Borgwardt, S, Glenthøj, B. Volumetric changes in the basal ganglia after antipsychotic monotherapy: a systematic review. Curr Med Chem
2013; 20: 438–47.
Ho, BC, Andreasen, NC, Ziebell, S, Pierson, R, Magnotta, V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry
2011; 68: 128–37.